Kenvue Inc
KVUE21.590USD
+0.150+0.70%
Handelsschluss 08/01, 16:00（ET）Kurse um 15 Minuten verzögert
41.43BMarktkapitalisierung
39.23KGV TTM
mehr Informationen über Kenvue Inc Unternehmen
Kenvue Inc. is a consumer health company. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
Unternehmensinformationen
BörsenkürzelKVUE
Name des UnternehmensKenvue Inc
IPO-datumMay 04, 2023
Gegründet am2022
CEOMr. Kirk L. Perry
Anzahl der mitarbeiter22000
WertpapierartOrdinary Share
GeschäftsjahresendeMay 04
Addresse1 Kenvue Way
StadtSUMMIT
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl07901
Telefon19088741200
Websitehttps://www.kenvue.com
BörsenkürzelKVUE
IPO-datumMay 04, 2023
Gegründet am2022
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
64.44K
+5.82%
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
56.32K
-14.66%
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
44.13K
+6.62%
Mr. Jan Meurer
Mr. Jan Meurer
Group President, North America
Group President, North America
33.18K
+15.35%
Ms. Luani Alvarado
Ms. Luani Alvarado
Chief People Officer
Chief People Officer
31.36K
+9.72%
Ms. Charmaine England
Ms. Charmaine England
Chief Growth Officer
Chief Growth Officer
29.06K
+5.68%
Mr. Michael E. Sneed
Mr. Michael E. Sneed
Independent Director
Independent Director
28.44K
+52.59%
Mr. Larry J. Merlo
Mr. Larry J. Merlo
Independent Chairman of the Board
Independent Chairman of the Board
27.46K
+124.86%
Mr. Matthew Orlando
Mr. Matthew Orlando
General Counsel
General Counsel
25.25K
+15.69%
Ms. Melanie L. Healey
Ms. Melanie L. Healey
Independent Director
Independent Director
17.80K
+122.51%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
64.44K
+5.82%
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
56.32K
-14.66%
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
44.13K
+6.62%
Mr. Jan Meurer
Mr. Jan Meurer
Group President, North America
Group President, North America
33.18K
+15.35%
Ms. Luani Alvarado
Ms. Luani Alvarado
Chief People Officer
Chief People Officer
31.36K
+9.72%
Ms. Charmaine England
Ms. Charmaine England
Chief Growth Officer
Chief Growth Officer
29.06K
+5.68%
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Face and Body Care
673.38M
18.00%
Cough, Cold and Allergy
598.56M
16.00%
Other Self Care
598.56M
16.00%
Pain Care
486.33M
13.00%
Other Essential Health
374.10M
10.00%
Other
1.01B
27.00%
Keine Daten
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Face and Body Care
673.38M
18.00%
Cough, Cold and Allergy
598.56M
16.00%
Other Self Care
598.56M
16.00%
Pain Care
486.33M
13.00%
Other Essential Health
374.10M
10.00%
Other
1.01B
27.00%
Aktionärsstatistik
Aktualisiert: Fri, May 16
Aktualisiert: Fri, May 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
12.15%
T. Rowe Price Associates, Inc.
10.85%
State Street Global Advisors (US)
6.26%
BlackRock Institutional Trust Company, N.A.
4.91%
MFS Investment Management
4.85%
Other
60.97%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
12.15%
T. Rowe Price Associates, Inc.
10.85%
State Street Global Advisors (US)
6.26%
BlackRock Institutional Trust Company, N.A.
4.91%
MFS Investment Management
4.85%
Other
60.97%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
56.49%
Investment Advisor/Hedge Fund
32.81%
Hedge Fund
4.38%
Research Firm
3.21%
Pension Fund
1.76%
Sovereign Wealth Fund
1.38%
Bank and Trust
1.18%
Family Office
0.19%
Family Office
0.19%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
2088
1.95B
101.44%
-295.31M
2025Q1
2078
1.95B
101.47%
-298.35M
2024Q4
1944
1.96B
102.60%
-253.31M
2024Q3
1828
1.91B
99.61%
-331.64M
2024Q2
1723
1.90B
99.19%
-79.08M
2024Q1
1598
1.90B
99.47%
-51.94M
2023Q4
1442
1.89B
98.66%
-22.82M
2023Q3
1206
1.90B
99.22%
-343.08M
2023Q2
232
1.95B
101.85%
+1.90B
2023Q1
1
--
0.00%
-14.23K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
228.31M
11.89%
+10.60M
+4.87%
Mar 31, 2025
T. Rowe Price Associates, Inc.
208.36M
10.85%
-33.69M
-13.92%
Mar 31, 2025
State Street Global Advisors (US)
120.27M
6.26%
-134.23K
-0.11%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
94.32M
4.91%
+1.26M
+1.36%
Mar 31, 2025
MFS Investment Management
93.09M
4.85%
-771.33K
-0.82%
Mar 31, 2025
Fidelity Management & Research Company LLC
92.37M
4.81%
-13.82M
-13.02%
Mar 31, 2025
Wellington Management Company, LLP
61.47M
3.2%
-6.89M
-10.08%
Mar 31, 2025
Geode Capital Management, L.L.C.
48.40M
2.52%
+2.33M
+5.05%
Mar 31, 2025
Harris Associates L.P.
26.88M
1.4%
-4.64M
-14.71%
Mar 31, 2025
Charles Schwab Investment Management, Inc.
25.61M
1.33%
+633.46K
+2.54%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: 3 hours ago
Aktualisiert: 3 hours ago
Name
Anteil
Renaissance IPO ETF
9.18%
TBG Dividend Focus ETF
3.64%
American Century Focused Large Cap Value ETF
3.63%
Brookstone Value Stock ETF
3.54%
Cullen Enhanced Equity Income ETF
3.4%
TrueShares Low Volatility Equity Income ETF
3.16%
Invesco S&P 500 Equal Weight Consumer Staples ETF
2.53%
VanEck Morningstar Wide Moat Value ETF
2.53%
ProShares Ultra Consumer Staples
2.52%
Consumer Staples Select Sector SPDR Fund
2.52%
Mehr Anzeigen
Renaissance IPO ETF
Anteil9.18%
TBG Dividend Focus ETF
Anteil3.64%
American Century Focused Large Cap Value ETF
Anteil3.63%
Brookstone Value Stock ETF
Anteil3.54%
Cullen Enhanced Equity Income ETF
Anteil3.4%
TrueShares Low Volatility Equity Income ETF
Anteil3.16%
Invesco S&P 500 Equal Weight Consumer Staples ETF
Anteil2.53%
VanEck Morningstar Wide Moat Value ETF
Anteil2.53%
ProShares Ultra Consumer Staples
Anteil2.52%
Consumer Staples Select Sector SPDR Fund
Anteil2.52%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
2.32B
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Jan 16, 2025
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Feb 26, 2025 going ex on Feb 12, 2025
Feb 12, 2025
Feb 26, 2025
Feb 12, 2025
Oct 17, 2024
KVUE.NB Final Cash Dividend of gross USD 0.205 paid on Nov 27, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 27, 2024
Nov 13, 2024
Jul 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Aug 28, 2024 going ex on Aug 14, 2024
Aug 14, 2024
Aug 28, 2024
Aug 14, 2024
Apr 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on May 22, 2024 going ex on May 07, 2024
May 08, 2024
May 22, 2024
May 07, 2024
Jan 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Feb 28, 2024 going ex on Feb 13, 2024
Feb 14, 2024
Feb 28, 2024
Feb 13, 2024
Oct 26, 2023
KVUE.NB Final Cash Dividend of gross USD 0.2 paid on Nov 22, 2023 going ex on Nov 07, 2023
Nov 08, 2023
Nov 22, 2023
Nov 07, 2023
Jul 20, 2023
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Sep 07, 2023 going ex on Aug 25, 2023
Aug 28, 2023
Sep 07, 2023
Aug 25, 2023
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
